Skip to content
Info@spinogenix.com
Monday – Friday 10 AM – 8 PM
Linkedin page opens in new window
X page opens in new window
Instagram page opens in new window
Vimeo page opens in new window
YouTube page opens in new window
Spinogenix
Restoring Synaptic Function Starts Today
About
About
Management Team
Board of Directors
Scientific Advisory Board
Science
Pipeline
Patients
Patients
Expanded Access Policy
Media
Press Releases
In The News
Blog
Contact
Search:
About
About
Management Team
Board of Directors
Scientific Advisory Board
Science
Pipeline
Patients
Patients
Expanded Access Policy
Media
Press Releases
In The News
Blog
Contact
News
FDA Clears Phase 1/2 Clinical Trial for Spinogenix’s ALS Treatment SPG302
October 1, 2024
Go to Top
